
ArsenalBio
Operator of a programmable cell therapy company intended to discover, develop, and commercialize curative immune cell therapies. The company offers a full-stack research and development engine that ge...
Valuation
$1.9B
Latest known
Share Price
N/A
Total Raised
$630.8M
Last Round
N/A